Company intelligence / Profile preview

Jupiter Endovascular

Menlo Park, California, United States

Ownership: Private
Development stage: Other

Overview

Jupiter Endovascular is developing the Vertex Pulmonary Embolectomy System, utilizing Endoportal Control technology, to treat acute pulmonary embolism. The device is designed to provide flexible navigation and fixable catheter support for aspiration, aiming for improved safety and efficacy. It is currently in the pivotal SPIRARE II trial in the US, following early human cases in the US and EU that demonstrated promising procedural success, high control, and safety in initial cases.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Jupiter Endovascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jupiter Endovascular.

Explore the full profile